MGCD-265抑制劑MGCD-265-analog (structurally related to MGCD-265) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
| 產(chǎn)品名稱： | MGCD-265 | ||
| 英文名： | Glesatinib | ||
| CAS NO.： | 875337-44-3 | ||
| 分子式： | C26H20FN5O2S2 | ||
| 分子量： | 517.597705841064 | ||
| 產(chǎn)品品牌： | targetmol | ||
| 產(chǎn)品規(guī)格： | 1mg | ||
